Veranova
- Company typePrivate
- Founded1780
- HeadquartersWayne, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
Veranova firmographics
Firmographics- Name
- Veranova
- Legal name
- Veranova Parent Holdco, L.P.
- Website
- https://veranova.com
- Company type
- Private
- Founded year
- 1780
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Veranova industry classification
Industry- Product category
- Pharmaceutical API Contract Development and Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Scientific Research and Development Services (5417)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
- akta.pro secondary industries
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
Keywords
Where Veranova is headquartered
LocationHeadquarters
- HQ city
- Wayne
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Veranova business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Custom API Development and Manufacturing Services: Fee-for-service CDMO model providing pharmaceutical companies with development and manufacturing services for active pharmaceutical ingredients. Services span from early-phase development through commercial manufacturing, with integrated project management and regulatory support. Revenue is generated through project-based contracts, scale-up fees, and manufacturing runs based on customer requirements.
- Generic API Products: Sale of generic active pharmaceutical ingredients including controlled substances. Portfolio includes APIs, reference standards, and controlled substance products. Revenue generated through product sales to pharmaceutical manufacturers.
- Solid Form and Particle Engineering Services: Specialized development services including crystallization development, amorphous solid dispersion, spray drying, polymorph screening, and particle size modification. Revenue generated through service contracts and project-based engagements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Veranova product offering
Product offeringCore offering
Veranova is a global Contract Development and Manufacturing Organization (CDMO) providing integrated development and manufacturing services for complex and highly potent active pharmaceutical ingredients (APIs). The company offers end-to-end capabilities spanning early-phase process and analytical development, solid form and particle engineering, custom API manufacturing at clinical and commercial scales, specialty modalities such as ADCs and TIDES, and licensed controlled substance manufacturing for pharmaceutical and biotech customers across the US and UK.
Product overview
Veranova is a global CDMO (Contract Development and Manufacturing Organization) providing integrated services across the pharmaceutical drug substance lifecycle. The company's unified platform encompasses CDMO Services as its core offering, with specialized sub-products including Solid Form & Particle Engineering (featuring Amorphous Solid Dispersion, Crystallization Development, Spray Drying, and Structure Confirmation via SCXRD), Process and Analytical Development, Custom API Manufacturing (with Highly Potent APIs and Controlled Substance Manufacturing), and Specialty Modalities (covering ADCs with Linkers/Payloads/Conjugates, PROTACs, PEGs and Lipids, and TIDES). The company also offers Generic API Products and operates the Pharmorphix® Solid State Services brand for specialized solid form sciences. A notable consumer product is Bitrex®, a bittering agent for child safety. Veranova serves pharmaceutical and biotech customers from GMP-certified facilities in the US and UK, supporting innovation from early-phase development through commercial-scale manufacturing.
Differentiator
Problem solved
Functional benefit
Brands
- Pharmorphix: Solid state services brand offering single crystal X-ray diffraction and solid form science expertise for early drug development.
Products and services
- CDMO Services Contract Development and Manufacturing Organization services spanning the full drug substance lifecycle from early development through commercial manufacturing. Targets pharmaceutical and biotech companies requiring external development and manufacturing partners for complex APIs.
- Solid Form & Particle Engineering Comprehensive solid form sciences including crystallization development, particle engineering, polymorph screening, salt and cocrystal screening, amorphous solid dispersion, and spray drying services. Used by pharmaceutical developers to optimize bioavailability and select optimal solid forms.
- Process and Analytical Development Phase-appropriate process development and analytical method development services including separations and purifications, technology transfer, and quality and regulatory affairs. Supports drug development lifecycle compliance with ICH, FDA, MHRA, and EMEA requirements.
- Custom API Manufacturing End-to-end custom active pharmaceutical ingredient manufacturing including multi-scale clinical and commercial API production. Includes complex small molecules, highly potent APIs, and Schedule I-V controlled substances under cGMP conditions.
- Specialty Modalities Specialized capabilities including antibody-drug conjugates (linkers, payloads, and conjugates), PEGs and lipids, PROTACs, and TIDES (nucleotides, oligonucleotides, and peptides). Targeted at novel therapeutic modalities.
- Generic API Products Portfolio of generic active pharmaceutical ingredients and controlled substances with reference standards and API life cycle management support. Sold to generic pharmaceutical manufacturers for formulation use.
- Bitrex The world's most bitter substance known, used as a safety component to make potentially harmful household, personal care, autocare, and pesticide products unpalatable and prevent accidental poisoning, especially in children. Licensed to partners such as Nutriband.
- Pharmorphix Solid State Services Specialized solid form sciences sub-brand providing polymorph screening, salt selection, crystallization development, cocrystal screening, and single crystal X-ray diffraction (SCXRD) services for early drug development customers.
Quantifiable outcome
- 18% of FDA-approved small molecule drugs since 2014 have collaborated with Veranova
- +4 more outcomes
Companies that use Veranova
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Veranova technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Veranova partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor.
- APIC (Active Pharmaceutical Ingredients Committee)minorAPIC is a sector group within Cefic (European Chemical Industry Council) focusing on worldwide GMP and regulatory matters relating to APIs and intermediates. Veranova is a member company, participating in industry advocacy and regulatory discussions.
- BPTF (Bulk Pharmaceutical Task Force)minorUS industry trade organization representing manufacturers of APIs, intermediates, and excipients. Addresses regulatory and quality issues related to cGMP compliance and advocates in dialogue with FDA and other regulatory authorities.
- SOCMA (Society of Chemical Manufacturers & Affiliates)minorSupports growth of specialty chemical industry through peer network, industry knowledge, and resources. Veranova has been recognized by SOCMA's Safety Recognition Program in 2023 and 2024.
- MassBiominorMassachusetts biotechnology and pharmaceutical industry association with 1,700+ member organizations. Drives innovation by fostering a supportive business environment in Massachusetts.
- DCAT (Drug, Chemical & Associated Technologies Association)minorOver 135-year-old not-for-profit business development association for bio/pharmaceutical sector companies. Provides insight into industry trends and best practices through expert-driven education.
- CIA (Chemical Industries Association)minorUK's leading trade association representing chemical and pharmaceutical companies. Provides expert advice, shares good practice, and reports on relevant policy developments with 200+ members.
- CEED (Centre for Engineering, Education and Development)minorPeer-to-peer best practice-sharing organization for manufacturing, engineering, and technology companies. Pools talents and resources to achieve operational excellence.
- SPAC (Scottish Patient Awareness Council)minorScottish life sciences platform for discussing best practices and sharing patient stories. Collaborates with Scottish Government, Scottish Enterprise, Edinburgh University.
- NutribandminorNutriband is a licensed partner of Bitrex, using Veranova's Bitrex technology in their innovative drug delivery systems and devices. Nutriband develops pharmaceutical products from pre-clinical testing through clinical manufacturing.
Scale indicators9 records
Recent moves9 records
Expansion highlights6 records
Veranova competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: Swiss-headquartered global CDMO leader offering mammalian and small molecule API services including HPAPI and ADC capabilities. Comparable as a comprehensive CDMO competitor to pharma/biotech sponsors, though substantially larger and more diversified across biologics, cell/gene therapy, and small molecules.
- Catalent (Novo Holdings): Large diversified CDMO with strong small molecule, biologics, and oral drug product capabilities. Competes with Veranova for outsourced pharmaceutical development and manufacturing programs across both early-phase and commercial supply.
- WuXi AppTec / STA Pharmaceutical: Asia-headquartered large CDMO offering end-to-end small molecule and biologics services. Competes with Veranova on price-sensitive commercial API programs and increasingly on complex modalities.
- Thermo Fisher Scientific (Patheon/CDMO): Pharma services division within Thermo Fisher encompassing API, oral solid dose, sterile fill-finish, and clinical trial material services. Directly comparable as a small molecule API CDMO serving large pharma and biotech sponsors.
Direct peers
- Alcami Corporation: US-based CDMO focused on small molecule API development and manufacturing, including sterile and parenteral capabilities. Comparable as a mid-sized pure-play API CDMO serving pharma and biotech.
- Piramal Pharma Solutions: CDMO with deep expertise in API development and manufacturing including HPAPIs, ADCs, and complex small molecules. Highly comparable service portfolio; notably Dr. Matteo Villain joined Veranova from Piramal, reinforcing direct competitive overlap.
- Carbogen Amcis: Specialist CDMO focused on highly potent and complex APIs including ADC payloads, with strong containment capabilities. Highly comparable to Veranova's HPAPI and ADC linker/payload service offering.
- Cambrex: Small molecule API CDMO with active pharmaceutical ingredient development and manufacturing capabilities across multiple sites. Privately held by Permira; directly comparable as a pure-play small molecule API CDMO competitor.
- Bachem Holding: Swiss-listed specialist CDMO focused on peptide and oligonucleotide (TIDES) manufacturing, the exact segment Veranova entered via the Villain hire. Comparable as a high-purity API manufacturer targeting complex modalities.
- Siegfried Holding: Swiss-listed CDMO specializing in small molecule API manufacturing including controlled substances and HPAPIs. Directly comparable in service offering and customer base; competes on complex chemistry capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Veranova social profiles
Digital presenceVeranova compliance and trust
Trust signalCompliance5 records
Veranova financial estimates
Financial estimateRevenue estimate
Valuation estimate
Veranova leadership team
Management profileNumber of profiles
Profiles17 records
Veranova subsidiaries and ownership
Company hierarchySubsidiaries4 records
Veranova funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Veranova M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Veranova
What does Veranova do?
Veranova is a global Contract Development and Manufacturing Organization (CDMO) providing integrated development and manufacturing services for complex and highly potent active pharmaceutical ingredients (APIs). The company offers end-to-end capabilities spanning early-phase process and analytical development, solid form and particle engineering, custom API manufacturing at clinical and commercial scales, specialty modalities such as ADCs and TIDES, and licensed controlled substance manufacturing for pharmaceutical and biotech customers across the US and UK.
Is Veranova a public or private company?
Veranova is a private company. It is classified as private equity controlled and is currently operating.
When was Veranova founded?
Veranova was founded in 1780. It employs 501 to 1,000 people.
Where is Veranova based?
Veranova is headquartered in Wayne, United States, in the North America region.
How does Veranova make money?
Three revenue lines are on record. Custom API Development and Manufacturing Services are the primary driver. The others are generic API Products and solid Form and Particle Engineering Services.
Who are Veranova's main competitors?
Broad incumbents on record are Lonza Group, Catalent (Novo Holdings), WuXi AppTec / STA Pharmaceutical and Thermo Fisher Scientific (Patheon/CDMO). Direct peers are Alcami Corporation, Piramal Pharma Solutions, Carbogen Amcis, Cambrex, Bachem Holding and Siegfried Holding.
Does Veranova have an API?
No public API is recorded for Veranova.
What industry is Veranova in?
Veranova's product category is Pharmaceutical API Contract Development and Manufacturing. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 3254 and its SIC code is 2833.